Knight Therapeutics Announces Approval of Additional Indication for MINJUVI® (tafasitamab) in Brazil
Go back to Knight Therapeutics Announces Approval of Additional Indication for MINJUVI® (tafasitamab) in Brazil| Com-Guard.com, Inc. (AMEX: GUD) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $0.00 | |||
| Open | $0.00 | 52 Week Low | $0.00 | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $0.00 | |||
| Volume | 4,000 | |||||
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 107.53 -0.93 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.46 | 52 Week High | $118.49 | |||
| Open | $108.35 | 52 Week Low | $55.00 | |||
| Day High | $110.75 | P/E | N/A | |||
| Day Low | $106.48 | EPS | $-0.56 | |||
| Volume | 1,832,380 | |||||
